AWM
ABVX

Avior Wealth Management’s Abivax ABVX Stock Holding History

Avior Wealth Management’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$405K Sell
3,037
-203
-6% -$23K 0.01% 574
2026
Q1 		$361K Buy
3,240
+444
+16% +$52.5K 0.01% 629
2025
Q4 		$377K Buy
+2,796
New +$305K 0.01% 546

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Avior Wealth Management's ABVX Position: Q2 2026 in Review

Avior Wealth Management reduced its Abivax (ABVX) stake by 6.3% in Q2 2026, selling an estimated $23K and leaving 3,037 shares worth $405K. The position accounts for 0.01% of the portfolio, ranked #574.

Avior Wealth Management first reported a position in ABVX in Q4 2025 and has held it in 3 quarters since. 302 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Avior Wealth Management held 3,037 shares of Abivax worth $405K as of Q2 2026.
  • Avior Wealth Management sold 203 Abivax shares in Q2 2026, an estimated $23K.
  • Abivax made up 0.01% of Avior Wealth Management's portfolio in Q2 2026, its #574 holding.
  • Avior Wealth Management first reported a position in Abivax in Q4 2025 and has held it in 3 quarters since.
  • 302 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Avior Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.